Albemarle Corporation (ALB)
$87.67
+1.03 (+1.17%)Delayed quote.
Price history
Daily close- Start
- $121.39
- Latest close
- $87.67
- Period change
- -27.78%
- Period low
- $87.67
- Period high
- $215.62
Key metrics
- Market cap
- $10.53B
- Volume
- 318.4K
- Average volume
- 2.38M
- 52-week range
- $87.27 – $221.00
- Beta
- 1.36
- Last dividend
- $1.63
- EPS (TTM)
- $4.36
- P/E ratio
- 20.11
- Revenue (TTM)
- $6.15B
- Net income (TTM)
- $681.63M
- Total assets
- $16.08B
- Total debt
- $1.88B
- Cash and equivalents
- $1.85B
Key financials (trailing twelve months).
Company profile
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Exchange
- NYSE
- CEO
- Jerry Kent Jr.
- Employees
- 7,800
- Headquarters
- Charlotte, NC, US
- IPO date
- 1994-02-22
- Website
- https://www.albemarle.com
Financial statements
Annual, last 3 fiscal years. Most recent period first. Reported in USD.
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Revenue | $5.14B | $5.38B | $9.62B |
| Gross profit | $671.62M | $60.24M | $1.20B |
| Operating income | $93.79M | -$636.01M | $241.12M |
| EBITDA | $558.00M | -$294.13M | $2.65B |
| Net income | -$510.63M | -$1.18B | $1.57B |
| Diluted EPS | -$5.75 | -$11.20 | $13.36 |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Cash and equivalents | $1.62B | $1.19B | $889.90M |
| Total assets | $16.37B | $16.61B | $18.27B |
| Total liabilities | $6.59B | $6.41B | $8.61B |
| Total debt | $3.30B | $3.62B | $4.28B |
| Shareholders’ equity | $9.53B | $9.96B | $9.41B |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | $1.28B | $687.88M | $1.33B |
| Capital expenditure | -$589.80M | -$1.68B | -$2.15B |
| Free cash flow | $692.47M | -$992.65M | -$827.96M |
Quarterly, last 6 quarters. Most recent period first. Reported in USD.
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.55B | $1.74B | $1.43B | $1.43B | $1.31B | $1.33B |
| Gross profit | $300.72M | $590.30M | $500.97M | $202.73M | $117.61M | $196.88M |
| Operating income | $148.16M | $452.94M | $233.51M | $48.25M | -$30.46M | $53.74M |
| EBITDA | $329.43M | $620.04M | $445.12M | -$22.94M | $36.94M | $287.96M |
| Net income | $296.75M | $479.96M | $319.09M | -$414.18M | -$160.69M | $22.90M |
| Diluted EPS | $2.15 | $3.22 | $2.34 | -$3.87 | -$1.72 | -$0.16 |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $1.85B | $1.63B | $1.09B | $1.62B | $1.93B | $1.81B |
| Total assets | $16.08B | $15.91B | $15.14B | $16.37B | $17.15B | $17.29B |
| Total liabilities | $5.26B | $5.41B | $5.03B | $6.59B | $6.88B | $6.79B |
| Total debt | $1.88B | $1.99B | $1.88B | $3.30B | $3.74B | $3.72B |
| Shareholders’ equity | $10.54B | $10.28B | $9.85B | $9.53B | $10.00B | $10.24B |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $405.80M | $710.00M | $346.24M | $388.49M | $355.60M | -$7.20M |
| Capital expenditure | -$80.37M | -$71.73M | -$98.68M | -$155.38M | -$132.16M | -$119.63M |
| Free cash flow | $325.42M | $638.27M | $247.57M | $233.10M | $223.44M | -$126.83M |